1. Home
  2. CODI vs ADCT Comparison

CODI vs ADCT Comparison

Compare CODI & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D/B/A Compass Diversified Holdings Shares of Beneficial Interest

CODI

D/B/A Compass Diversified Holdings Shares of Beneficial Interest

HOLD

Current Price

$6.33

Market Cap

480.8M

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$4.11

Market Cap

484.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CODI
ADCT
Founded
2005
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
480.8M
484.4M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CODI
ADCT
Price
$6.33
$4.11
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$8.00
$7.50
AVG Volume (30 Days)
1.2M
812.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.64%
N/A
EPS Growth
N/A
44.90
EPS
N/A
N/A
Revenue
N/A
$70,837,000.00
Revenue This Year
$0.93
$14.96
Revenue Next Year
$6.35
$1.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.84
52 Week Low
$4.58
$1.05
52 Week High
$20.07
$4.80

Technical Indicators

Market Signals
Indicator
CODI
ADCT
Relative Strength Index (RSI) 42.19 51.41
Support Level $6.15 $3.25
Resistance Level $7.33 $4.71
Average True Range (ATR) 0.56 0.25
MACD -0.16 -0.02
Stochastic Oscillator 0.24 29.76

Price Performance

Historical Comparison
CODI
ADCT

About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest

Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: